Most of the works about single-photon detectors rely on Single Photon Avalanche Diodes (SPADs) designed with dedicated technological processes in order to achieve single-photon sensitivity and excellent timing resolution. Instead, this paper focuses on the implementation of high-performance SPADs detectors manufactured in a standard 0.35-micron opto-CMOS technology provided by AMS. We propose a series of low-noise SPADs designed with a variable pitch from 20 μm down to 5 μm. This opens the further way to the integration of large arrays of optimized SPAD pixels with pitch of a few micrometers in order to provide high-resolution single-photon imagers. We experimentally demonstrate that a 20-micron SPAD appears as the most relevant detector in terms of Signal-to-Noise ratio, enabling emergence of large arrays of SPAD.
International audienceDue to its sensitivity and speed, the detector still widely used in Cerenkov astrophysics experiments remains the PhotoMultiplier Tube (PMT). For instance, recent pathbreaking experiments in Very High Energy astrophysics (VHE), such as MAGIC and HESS, have used mainstream PMT technology (Aharonian et al, Astron Astrophys 492(1):L25-L28, 2008). Moreover the Cerenkov Telescope Array (CTA) which is now in its design phase, is also planed to be based on PMT's. However, there are some disadvantages to the PMT technology: the rather poor quantum efficiency, the use of high voltages, the high cost when used in large number in a matrix arrangement and the large weight. Hence, we have investigated the possibility to design future Cerenkov telescopes based on solid state technology, specifically Geiger avalanche photodiodes. In a preliminary developmen
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.